全文获取类型
收费全文 | 6605篇 |
免费 | 390篇 |
国内免费 | 43篇 |
专业分类
耳鼻咽喉 | 77篇 |
儿科学 | 391篇 |
妇产科学 | 122篇 |
基础医学 | 725篇 |
口腔科学 | 204篇 |
临床医学 | 509篇 |
内科学 | 1781篇 |
皮肤病学 | 85篇 |
神经病学 | 495篇 |
特种医学 | 188篇 |
外科学 | 1038篇 |
综合类 | 124篇 |
一般理论 | 3篇 |
预防医学 | 282篇 |
眼科学 | 168篇 |
药学 | 406篇 |
中国医学 | 26篇 |
肿瘤学 | 414篇 |
出版年
2023年 | 54篇 |
2022年 | 110篇 |
2021年 | 278篇 |
2020年 | 169篇 |
2019年 | 222篇 |
2018年 | 295篇 |
2017年 | 186篇 |
2016年 | 246篇 |
2015年 | 221篇 |
2014年 | 322篇 |
2013年 | 385篇 |
2012年 | 537篇 |
2011年 | 561篇 |
2010年 | 305篇 |
2009年 | 272篇 |
2008年 | 429篇 |
2007年 | 422篇 |
2006年 | 371篇 |
2005年 | 330篇 |
2004年 | 318篇 |
2003年 | 252篇 |
2002年 | 235篇 |
2001年 | 39篇 |
2000年 | 28篇 |
1999年 | 32篇 |
1998年 | 44篇 |
1997年 | 26篇 |
1996年 | 26篇 |
1995年 | 26篇 |
1994年 | 26篇 |
1993年 | 9篇 |
1992年 | 19篇 |
1991年 | 11篇 |
1990年 | 10篇 |
1989年 | 13篇 |
1988年 | 10篇 |
1987年 | 10篇 |
1986年 | 8篇 |
1984年 | 8篇 |
1983年 | 12篇 |
1982年 | 6篇 |
1981年 | 12篇 |
1980年 | 7篇 |
1978年 | 10篇 |
1977年 | 7篇 |
1969年 | 5篇 |
1963年 | 5篇 |
1962年 | 5篇 |
1933年 | 5篇 |
1929年 | 5篇 |
排序方式: 共有7038条查询结果,搜索用时 46 毫秒
101.
Yang Kun Perez Manuela Hossu Gabriela Hubert Nicolas Perrenot Cyril Hubert Jacques 《Surgical endoscopy》2017,31(1):100-106
Surgical Endoscopy - In robotic surgery, the professional ergonomic habit of using an armrest reduces operator fatigue and increases the precision of motion. We designed and validated a pressure... 相似文献
102.
Hegyi L, Thway K, Fisher C & Sheppard M N (2012) Histopathology 61, 966–973 Primary cardiac sarcomas may develop from resident or bone marrow‐derived mesenchymal stem cells: use of immunohistochemistry including CD44 and octamer binding protein 3/4 Aims: To provide evidence that cardiac sarcomas ‘not otherwise specified’ express markers that might indicate their cellular origin or identify any lines of differentiation. Methods and results: We reviewed all 11 cases of primary undifferentiated cardiac sarcomas found in the archives of the Royal Marsden and Royal Brompton Hospitals, London, UK during the period 2000–2009. Five cases with appropriate consent and archived material were investigated using immunohistochemistry. We found that the spindle, pleomorphic or occasionally epithelioid cell sarcomas showed no lineage‐specific differentiation other than partial myofibroblastic or ‘myoid’ differentiation (all cases). All tumours showed some degree of cytoplasmic positivity for the mesenchymal stem cell marker CD44. In contrast, no nuclear octamer binding protein 3/4 (Oct3/4) expression was seen in any of the tumours, although very patchy cytoplasmic positivity was seen in some tumours. Conclusions: The cytoplasmic positivity for CD44 and the absence of nuclear Oct3/4 suggest that the cells of these sarcomas may represent ‘daughter’ stem cells that no longer have the capacity for tumour initiation, but have subsequently developed new lines of partial differentiation. Primary cardiac sarcomas may arise from mesenchymal stem cells with the ability to generate tumours with multilineage differentiation. 相似文献
103.
104.
Sanjeev Singh Himanshu Pratap Saket Agarwal Aditya Singh Deepak Kumar Satsangi 《Indian Journal of Thoracic and Cardiovascular Surgery》2011,27(2):76-82
Background
The decision to preserve the pulmonary valve during intracardiac repair of Tetralogy of Fallot [TOF] is traditionally based on the intra-operative measurement of pulmonary annulus by a Hegar dilator as per Rowlatt’s table. We sought to evaluate if there can be flexibility in not using a transannular patch repair in Indian population with mildly hypoplastic pulmonary annulus. 相似文献105.
106.
Dalton HR Stableforth W Thurairajah P Hazeldine S Remnarace R Usama W Farrington L Hamad N Sieberhagen C Ellis V Mitchell J Hussaini SH Banks M Ijaz S Bendall RP 《European journal of gastroenterology & hepatology》2008,20(8):784-790
AIMS: To report the natural history of autochthonous hepatitis E and hepatitis E virus (HEV) IgG seroprevalence in Southwest England. METHODS: Patients with unexplained hepatitis were tested for hepatitis E and cases followed until recovery or death. Five hundred blood donors, 336 individuals over the age of 60 years and 126 patients with chronic liver disease were tested for HEV IgG. RESULTS: Forty cases of autochthonous hepatitis E (genotype 3) were identified. Hepatitis E was anicteric in 25% of cases and usually caused a self-limiting hepatitis predominantly in elderly Caucasian males. Six of 40 had a significant complication and three patients died, two of who had previously undiagnosed cirrhosis. Hepatitis E shows a seasonal variation with peaks in the spring and summer and no cases in November and December. HEV IgG prevalence increases with age, is more common in men and is 16% in blood donors, 13% in patients with chronic liver disease and 25% in individuals over 60 years. CONCLUSION: Autochthonous hepatitis E is more common than previously recognized, and should be considered in the differential diagnosis in patients with hepatitis, whatever their age or travel history. It carries a significant morbidity and when seen in the context of chronic liver disease carries an adverse prognosis. 相似文献
107.
Ujjwal Sonika Shekhar Jadaun Gyan Ranjan Gyanranjan Rout Deepak Gunjan Saurabh Kedia Baibaswata Nayak Shalimar 《Indian journal of gastroenterology》2018,37(1):50-57
Background and Aims
Various prognostic scores are available for predicting outcome in acute-on-chronic liver failure (ACLF). We compared the available prognostic models as predictors of outcome in alcohol-related ACLF patients.Methods
All consecutive patients with alcohol-related ACLF were included. At admission, prognostic indices-acute physiology and chronic health evaluation score (APACHE II), model for end-stage liver disease (MELD), MELD-Na, Maddrey’s discriminant function (DF), age-bilirubin-INR-creatinine (ABIC), and Chronic Liver Failure Consortium (CLIF-C) ACLF score (CLIF-C ACLF) score were calculated. Receiver operator characteristic (ROC) curves were plotted for all prognostic scores with in-hospital, 90-day, and 1-year mortality as outcome.Results
Of the 171 patients, 170 were males, and grade 1 ACLF in 20 (11.7%), grade 2 in 52 (30.4%), and grade 3 in 99 (57.9%) patients. One hundred and nineteen (69.6%) died in-hospital. The median (IQR) Maddrey’s score, MELD, MELD-Na, ABIC, APACHE II, and CLIF-C ACLF were 87.8 (66.5–123.0), 33.1 (27.6–40.0), 34.4 (29.5–40.0), 8.5 (7.3–9.6), 15 (12–21), and 51.1 (44.1–56.4), respectively. On multivariate Cox regression analysis, independent predictors of in-hospital outcome were presence of hepatic encephalopathy (early HR, 2.078; 95%CI, 1.173–3.682, p?=?0.012 and advanced, HR, 2.330; 95% CI, 1.270–4.276, p?=?0.006), elevated serum creatinine (HR, 1.140; 95% CI, 1.023–1.270, p?=?0.018), and infection at admission (HR, 1.874; 95% CI, 1.160–23.029, p?=?0.010). On comparison of ROC curves, APACHE II and CLIF-C ACLF AUROC were significantly higher than MELD, MELD-Na, DF, and ABIC (p?<?0.05) for predicting in-hospital, 90-day, and 1-year mortality. The AUROC was highest for APACHE II followed by CLIF-C ACLF (Hanley and McNeil, p?=?0.660).Conclusions
Alcohol-related ACLF has high in-hospital mortality. Among the available prognostic scores, CLIF-C ACLF and APACHE II perform best.108.
109.
110.
Hasan K. Siddiqi Brittany Weber Guohai Zhou James Regan Jesse Fajnzylber Kendyll Coxen Heather Corry Xu G. Yu Marcelo DiCarli Jonathan Z. Li Deepak L. Bhatt 《The American journal of medicine》2021,134(4):542-546
BackgroundPatients with coronavirus disease 2019 (COVID-19) have a high prevalence of detectable troponin and myocardial injury. In addition, a subset of patients with COVID-19 has detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral loads. The objective of this study was to understand the relationship among SARS-CoV-2 viremia, detectable troponin, and myocardial injury in hospitalized patients with COVID-19.MethodsSARS-CoV-2 plasma viral load was measured in plasma samples drawn from patients hospitalized for COVID-19 at 2 academic medical centers. Baseline characteristics and clinically obtained high-sensitivity cardiac troponin T (hs-cTnT) values were abstracted from the medical record. The main outcome was detectable hs-cTnT (≥6 ng/mL) and myocardial injury (hs-cTnT ≥14 ng/mL; >99th percentile for assay).ResultsA total of 70 hospitalized patients with COVID-19 were included in this study, with 39% females and median age 58 ± 17 years; 21 patients (30%) were found to have detectable SARS-CoV-2 viral load and were classified in the viremia group. Patients with viremia were significantly older than those without viremia. All of the patients with viremia (100%) had detectable troponin during hospitalization compared with 59% of patients without viremia (P = 0.0003). Myocardial injury was seen in 76% of patients with viremia and 38% of those patients without viremia (P = 0.004).ConclusionsHospitalized patients with COVID-19 with SARS-CoV-2 viremia have a significantly higher prevalence of detectable troponin and myocardial injury during their hospitalization compared with patients who did not. This first report of the relationship among SARS-CoV-2 viremia, detectable troponin, and myocardial injury in patients with COVID-19 points to additional mechanistic pathways that require deeper study to understand the complex interplay among these unique findings, cardiovascular outcomes, and mortality in COVID-19. 相似文献